Walter J. Paulus
Vrije Universiteit Amsterdam
H-index: 84
Europe-Netherlands
Top articles of Walter J. Paulus
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Paving the Road for Interleukin-6 Inhibition in Heart Failure With Preserved Ejection Fraction | Walter J Paulus | 2023/11/1 | |
Early Appearance of Myocardial Fibrosis in Restrictive Diabetic Cardiomyopathy | Walter J Paulus | 2023/7 | |
Natriuretic peptide levels and stages of left ventricular dysfunction in heart failure with preserved ejection fraction | Biomedicines | Elisa Dal Canto Marielle Scheffer Kirsten Kortekaas Annet Driessen-Waaijer Walter J Paulus | 2023/3/13 |
Geranylgeranylacetone reduces cardiomyocyte stiffness and attenuates diastolic dysfunction in a rat model of cardiometabolic syndrome | Physiological reports | Mark T Waddingham Vasco Sequeira Diederik WD Kuster Elisa Dal Canto M Louis Handoko | 2023/11 |
Heart failure with preserved ejection fraction | Cardiology in Review | Marwan F Jumean Marvin A Konstam | 2015/7/1 |
Co-morbidities | Oxford Textbook of Heart Failure | L van Heerebeek Walter J Paulus Hannah ZR McConkey Bernard Prendergast Andrew L Clark | 2022/5/5 |
Border disputes between heart failure phenotypes | Circulation | Walter J Paulus | 2022/5/3 |
Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction | Elisa Dal Canto Sharon Remmelzwaal Adriana Johanne van Ballegooijen M Louis Handoko Stephane Heymans | 2022/1 | |
Treatment of heart failure with preserved ejection fraction | Daniel N Silverman Sanjiv J Shah | 2019/4 | |
AHA Journals | Hypertension | Wenlu Ye Kyle Steenland Ashlinn Quinn Jiawen Liao Kalpana Balakrishnan | 2022/8/1 |
Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score | ESC heart failure | Olivier Huttin Alan G Fraser Lars H Lund Erwan Donal Cecilia Linde | 2021/6 |
From systemic inflammation to myocardial fibrosis: the heart failure with preserved ejection fraction paradigm revisited | Walter J Paulus Michael R Zile | 2021/5/14 | |
Adhesion molecules in early adulthood predict heart failure with preserved ejection fraction at older age | Walter J Paulus | 2020/5/5 | |
Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial | ESC heart failure | Mariëlle Scheffer Annet Driessen‐Waaijer Nazha Hamdani Jochem WD Landzaat Nini H Jonkman | 2020/12 |
Transitioning from preclinical to clinical heart failure with preserved ejection fraction: a mechanistic approach | Antoni Bayes-Genis Felipe Bisbal Julio Núñez Enrique Santas Josep Lupón | 2020/4/13 | |
Sex differences in circulating proteins in heart failure with preserved ejection fraction | Biology of sex Differences | Susan Stienen Joao Pedro Ferreira Masatake Kobayashi Gregoire Preud’homme Daniela Dobre | 2020/12 |
Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic … | Biomarkers | Susan Stienen João Pedro Ferreira Masatake Kobayashi Gregoire Preud’homme Daniela Dobre | 2020/2/17 |
Deliberating the diagnostic dilemma of heart failure with preserved ejection fraction | Jennifer E Ho Margaret M Redfield Gregory D Lewis Walter J Paulus Carolyn SP Lam | 2020/11/3 | |
Unfolding discoveries in heart failure | Walter J Paulus | 2020/2/13 | |
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review | Michiel THM Henkens Sharon Remmelzwaal Emma L Robinson Adriana J van Ballegooijen Arantxa Barandiarán Aizpurua | 2020/9 |
